Navigating the 2026 Pharmacy Landscape: DTC Programs, TrumpRx, and Maximum Fair Price Challenges

2025 was an interesting year for pharmacy, with many changes to the industry. Rite Aid shut its last store after 63 years in business. The proliferation of AI (artificial intelligence) has enhanced the managed care process, helping to streamline the prior authorization process, and a government shutdown caused delays in new drug reviews and approvals. With 2025 coming to a close, we now look ahead to 2026 to see what changes the industry may have in store.

This post is for subscribers only

Become a member to get access to all content

Subscribe now